HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention

TUCSON, Ariz. , May 18, 2023 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its management team will present the advantages of its proprietary drug discovery engine at the 2023